The Department of Health and Human Services issued INFORMATIONAL LETTER NO. 2352-MC-FFS outlining the following August 2022 Iowa Medicaid Pharmacy Program Changes effective August 1, 2022.
- New Drug Prior Authorization (PA) Criteria
- Finerenone (Kerendia)
- Odevixibat (Bylvay)
- Pegcetacoplan (Empaveli)
- Changes to Existing PA Criteria
- PCSK9 Inhibitors
- Point of Sale Billing Updates:
- ProDUR Quantity Limits
- Drug Utilization Review (DUR) Update
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.